Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
5
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
merck
startups
abbvie
alzheimer's disease
celgene
deals
fda
johnson & johnson
medicare
What
bio
companies
5
×
roundup
5
×
drug
life
nash
news
price
science
week
alzheimer’s
approval
approved
arena’s
biogen’s
biopharmaceutical
black
bounty
cig
comeback
continue
convo
corner
deals
debut
delivered
diamond
diamond’s
different
digital
disease
earlier
epidemic
expressing
fail
failures
fatty
fda
frenzied
gene
Language
unset
Current search:
national
×
biotech
×
cancer
×
" raleigh-durham blog main "
×
companies
×
roundup
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More